MX2013006877A - Composiciones farmaceuticas para inhibidores selectivos del factor xa para administracion oral. - Google Patents
Composiciones farmaceuticas para inhibidores selectivos del factor xa para administracion oral.Info
- Publication number
- MX2013006877A MX2013006877A MX2013006877A MX2013006877A MX2013006877A MX 2013006877 A MX2013006877 A MX 2013006877A MX 2013006877 A MX2013006877 A MX 2013006877A MX 2013006877 A MX2013006877 A MX 2013006877A MX 2013006877 A MX2013006877 A MX 2013006877A
- Authority
- MX
- Mexico
- Prior art keywords
- oral administration
- selective factor
- pharmaceutical compositions
- inhibitors
- enhancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención provee composiciones farmacéuticas para administración oral que comprenden una cantidad terapéuticamente eficaz de un inhibidor selectivo del factor Xa, o una sal farmacéuticamente aceptable del mismo, y un mejorador; en donde el mejorador es un ácido graso de cadena media, o una sal, éster, éter o derivado de un ácido graso de cadena media, y tiene una longitud de cadena de carbono de 4 a 20 átomos de carbono; la presente invención también provee un método para obtener una biodisponibilidad reproducible de un inhibidor selectivo del factor Xa en un sujeto después de su administración oral, que comprende administrar por vía oral una composición farmacéutica como la que se menciona arriba.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42326110P | 2010-12-15 | 2010-12-15 | |
PCT/US2011/052963 WO2012082209A1 (en) | 2010-12-15 | 2011-09-23 | Pharmaceutical compositions of selective factor xa inhibitors for oral administration |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2013006877A true MX2013006877A (es) | 2013-07-05 |
Family
ID=46234738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013006877A MX2013006877A (es) | 2010-12-15 | 2011-09-23 | Composiciones farmaceuticas para inhibidores selectivos del factor xa para administracion oral. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20120156294A1 (es) |
EP (1) | EP2651395A4 (es) |
JP (1) | JP2013545802A (es) |
KR (1) | KR20140046395A (es) |
CN (1) | CN103370051A (es) |
AU (1) | AU2011341637A1 (es) |
BR (1) | BR112013014940A2 (es) |
CA (1) | CA2819108A1 (es) |
MX (1) | MX2013006877A (es) |
WO (1) | WO2012082209A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7658938B2 (en) | 1999-02-22 | 2010-02-09 | Merrion Reasearch III Limited | Solid oral dosage form containing an enhancer |
US20110182985A1 (en) * | 2010-01-28 | 2011-07-28 | Coughlan David C | Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof |
WO2012094598A2 (en) | 2011-01-07 | 2012-07-12 | Merrion Research Iii Limited | Pharmaceutical compositions of iron for oral administration |
US10265384B2 (en) | 2015-01-29 | 2019-04-23 | Novo Nordisk A/S | Tablets comprising GLP-1 agonist and enteric coating |
CN108148102A (zh) * | 2016-12-03 | 2018-06-12 | 烟台东诚药业集团股份有限公司 | 喷雾干燥法制备低水分磺达肝癸钠原料药 |
KR20190130411A (ko) | 2018-05-14 | 2019-11-22 | 신일제약주식회사 | 아픽사반 약제학적 제제 및 그의 제조방법 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2363123C (en) * | 1999-02-22 | 2011-09-06 | Kenneth Iain Cumming | Solid oral dosage form containing an enhancer |
WO2002064148A2 (en) * | 2001-02-16 | 2002-08-22 | Shimizu Pharmaceutical Co., Ltd. | Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders |
US20070219131A1 (en) * | 2004-04-15 | 2007-09-20 | Ben-Sasson Shmuel A | Compositions capable of facilitating penetration across a biological barrier |
US20070212395A1 (en) * | 2006-03-08 | 2007-09-13 | Allergan, Inc. | Ocular therapy using sirtuin-activating agents |
ES2426445T3 (es) * | 2006-04-07 | 2013-10-23 | Merrion Research Iii Limited | Forma de dosificación oral sólida que contiene un potenciador |
US8999383B2 (en) * | 2008-05-07 | 2015-04-07 | Merrion Research Iii Limited | Compositions of GnRH related compounds and processes of preparation |
EP2343982B1 (en) * | 2008-09-17 | 2017-03-22 | Chiasma Inc. | Pharmaceutical compositions and related methods of delivery |
US9089484B2 (en) * | 2010-03-26 | 2015-07-28 | Merrion Research Iii Limited | Pharmaceutical compositions of selective factor Xa inhibitors for oral administration |
-
2011
- 2011-09-23 US US13/242,601 patent/US20120156294A1/en not_active Abandoned
- 2011-09-23 AU AU2011341637A patent/AU2011341637A1/en not_active Abandoned
- 2011-09-23 CA CA2819108A patent/CA2819108A1/en not_active Abandoned
- 2011-09-23 CN CN2011800604167A patent/CN103370051A/zh active Pending
- 2011-09-23 WO PCT/US2011/052963 patent/WO2012082209A1/en active Application Filing
- 2011-09-23 BR BR112013014940A patent/BR112013014940A2/pt not_active IP Right Cessation
- 2011-09-23 KR KR1020137017419A patent/KR20140046395A/ko not_active Application Discontinuation
- 2011-09-23 EP EP11849444.2A patent/EP2651395A4/en not_active Withdrawn
- 2011-09-23 MX MX2013006877A patent/MX2013006877A/es unknown
- 2011-09-23 JP JP2013544467A patent/JP2013545802A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20120156294A1 (en) | 2012-06-21 |
JP2013545802A (ja) | 2013-12-26 |
KR20140046395A (ko) | 2014-04-18 |
AU2011341637A1 (en) | 2013-06-20 |
EP2651395A1 (en) | 2013-10-23 |
CN103370051A (zh) | 2013-10-23 |
EP2651395A4 (en) | 2014-05-07 |
WO2012082209A1 (en) | 2012-06-21 |
CA2819108A1 (en) | 2012-06-21 |
BR112013014940A2 (pt) | 2016-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2013006877A (es) | Composiciones farmaceuticas para inhibidores selectivos del factor xa para administracion oral. | |
PH12012500765A1 (en) | Boronic acids and esters as inhibitors of fatty acid amide hydrolase | |
PH12015500930B1 (en) | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | |
WO2012079092A3 (en) | Testosterone undecanoate compositions | |
TN2012000413A1 (en) | Pyrrolopyrimidine compounds as inhibitors of cdk4/6 | |
WO2007145991A3 (en) | Anti-inflammatory and analgesic compositions and related methods | |
WO2010136474A3 (en) | Substituted aminobutyric derivatives as neprilysin inhibitors | |
NZ619076A (en) | Isoxazolines as inhibitors of fatty acid amide hydrolase | |
UA93393C2 (uk) | 1,3-діоксанкарбонові кислоти | |
EP4342546A3 (en) | Methods of reducing the risk of a cardiovascular event in a subject on statin therapy | |
TN2011000400A1 (en) | Inhibitors of beta-secretase | |
MX2011010311A (es) | Formulaciones farmaceuticas que comprenden derivados de nitrocatecol y metodos para hacer las mismas. | |
TW200745097A (en) | 4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors | |
MX2011010415A (es) | Formulaciones farmaceuticas que comprenden derivados de nitrocatecol y metodos para hacer las mismas. | |
WO2008109991A8 (en) | Inhibitors of carnitine palmitoyltransferase and treating cancer | |
MA34055B1 (fr) | Chlorhydrate d'agomelatine hydrate et sa preparation | |
EP2417115A4 (en) | FATTY ACID AMIDE HYDROLASE INHIBITORS | |
MX339685B (es) | Formulaciones de (trimetoxifenilamino) pirimidinilo nuevas. | |
MY156278A (en) | Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones | |
WO2011107877A3 (en) | Compounds and compositions and their use in the treatment of diseases related to copper retention | |
NZ601343A (en) | Oral liquid pharmaceutical composition of nifedipine | |
WO2014037833A3 (en) | Compositions and methods for treatment of inflammation and lipid disorders | |
NZ597861A (en) | 2-amino-2-phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same | |
MX2009013240A (es) | Derivados de carboxamida heterociclicos, su uso farmaceutico y composiciones. | |
UA86561C2 (ru) | ЭТИЛОВЫЙ ЭСТЕР 9-МЕТИЛ-3-ОКСО-2,3-ДИГИДРОТИЕНО[3,2-e][1,2,4]ТРИАЗОЛО[4,3-c]ПИРИМИДИН-8-КАРБОНОВОЙ КИСЛОТИ, КОТОРЫЙ ПРОЯВЛЯЕТ АНАЛЬГЕТИЧЕСКУЮ И ПРОТИВОВОСПАЛИТЕЛЬНУЮ АКТИВНОСТЬ |